A 0.5 mg daily dose of colchicine significantly reduces the risk of first and total ischemic cardiovascular events in patients who recently had a myocardial infarction (MI), according to results of the COLCOT study presented Saturday at American Heart Association Scientific Sessions 2019 in Philadelphia.